Related references
Note: Only part of the references are listed.Chorioallantoic membrane (CAM) assay to study treatment effects in diffuse intrinsic pontine glioma
Erica A. Power et al.
PLOS ONE (2022)
Pomegranate (Punica granatum) Fruit Extract Suppresses Cancer Progression and Tumor Angiogenesis of Pancreatic and Colon Cancer in Chick Chorioallantoic Membrane Model
Thangirala Sudha et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)
Laser speckle contrast analysis (LASCA) technology for the semiquantitative measurement of angiogenesis in in-ovo-tumor-model
Eric Pion et al.
MICROVASCULAR RESEARCH (2021)
Tumor grafted - chick chorioallantoic membrane as an alternative model for biological cancer research and conventional/nanomaterial-based theranostics evaluation
Ana Katrina Mapanao et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Assessment of breast cancer primary tumor material in a 3D in vivo model
Cynthia Kohl et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2021)
The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model
Khaoula Talbi et al.
FASEB JOURNAL (2021)
Role of oxygen and the HIF-pathway in polycystic kidney disease
Bjoern Buchholz et al.
CELLULAR SIGNALLING (2020)
Optimization of Renal Organoid and Organotypic Culture for Vascularization, Extended Development, and Improved Microscopy Imaging
Susanna Kaisto et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2020)
Chick embryo chorioallantoic membrane as a suitable in vivo model to evaluate drug delivery systems for cancer treatment: A review
Francesca Damiani Victorelli et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Extended analysis of intratumoral heterogeneity of primary osteosarcoma tissue using 3D-in-vivo-tumor-model
Anna-Lena Feder et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2020)
3D monitoring of tumor volume in an in vivo model
Johannes Troebs et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2020)
Cyst growth in ADPKD is prevented by pharmacological and genetic inhibition of TMEM16A in vivo
Ines Cabrita et al.
NATURE COMMUNICATIONS (2020)
Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing
P. Pawlikowska et al.
SCIENTIFIC REPORTS (2020)
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
Hannah A. Blair
DRUGS (2019)
Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells
Elena Garreta et al.
NATURE MATERIALS (2019)
HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease
Andre Kraus et al.
KIDNEY INTERNATIONAL (2018)
First experience of chick chorioallantoic membrane (CAM) assay in the clinical work flow with oral squamous cell carcinoma patients
Philipp Kauffmann et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2018)
Polycystic kidney disease
Carsten Bergmann et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Riluzole: a potential therapeutic intervention in human brain tumor stem-like cells
Swetlana Sperling et al.
ONCOTARGET (2017)
Presentation of a variation of the chorioallantoic membrane set up as a potential model for individual therapy for squamous cell carcinoma of the oropharynx
P. Kauffmann et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2017)
Hypoxia inhibits nephrogenesis through paracrine Vegfa despite the ability to enhance tubulogenesis
Gunnar Schley et al.
KIDNEY INTERNATIONAL (2015)
The chicken chorioallantoic membrane model in biology, medicine and bioengineering
Patrycja Nowak-Sliwinska et al.
ANGIOGENESIS (2014)
Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells
Bjoern Buchholz et al.
KIDNEY INTERNATIONAL (2014)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease
Sara Terryn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Why kidneys fail in autosomal dominant polycystic kidney disease
Jared J. Grantham et al.
NATURE REVIEWS NEPHROLOGY (2011)
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
Gerd Walz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polycystic Kidney Disease
Peter C. Harris et al.
ANNUAL REVIEW OF MEDICINE (2009)
Autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
LANCET (2007)
Share Paper
